Assessment of treatment efficacy and adverse effects of Microrelin in patient with prostate cancer.
Not Applicable
- Conditions
- Prostate cancer.Malignant neoplasm of prostate
- Registration Number
- IRCT201109067457N4
- Lead Sponsor
- Pooyesh darou company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
1- High risk prostate cancer with PSA>20 and/or GS>=8 with extraprostatic extension and unsuitable for surgery.
2- Patients with bone metastases.
3- No history of surgery or radiotherapy for prostate cancer.
4- No history of other malignancy or consumption of other hormonal agents except microrelin.
5- Pelvic lymph node involvement .
Exclusion criteria:
1- Surgery or raditherapy for prostate cancer.
2- Microrelin withdrawal
3- Coexistance of other malignancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method